OCEA vs OBK: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

OBK has stronger fundamentals based on our AI analysis.

OCEA
Ocean Biomedical, Inc.
STRONG SELL
89%
Confidence
VS
OBK
Origin Bancorp, Inc.
HOLD
68%
Confidence

OCEA vs OBK Fundamental Comparison

Metric OCEA OBK
Revenue $-2.0M $538.0M
Net Income $-8.2M $75.2M
Net Margin 402.7% 14.0%
ROE N/A 6.0%
ROA -520.9% 0.8%
Current Ratio 0.06x N/A
Debt/Equity N/A 0.00x
EPS $-0.09 $2.40

Green = Better metric | Red = Weaker metric

View Full OCEA Analysis →
View Full OBK Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OCEA vs AAPL OBK vs MSFT OCEA vs GOOGL OBK vs AMZN

OCEA vs OBK: Frequently Asked Questions

Is OCEA or OBK a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), OBK has stronger fundamentals. OCEA is rated STRONG SELL (89% confidence) while OBK is rated HOLD (68% confidence). This is not investment advice.

How does OCEA compare to OBK fundamentally?

Ocean Biomedical, Inc. has ROE of N/A vs Origin Bancorp, Inc.'s 6.0%. Net margins are 402.7% vs 14.0% respectively.

Which stock pays higher dividends, OCEA or OBK?

OCEA has a dividend yield of N/A or no dividend while OBK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OCEA or OBK for long term?

For long-term investing, consider that OCEA has STRONG SELL rating with 89% confidence, while OBK has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OCEA vs OBK?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OCEA vs OBK, the AI consensus favors OBK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.